INTERNATIONAL PHARMACEUTICAL FEDERATION
7th FIP Pharmaceutical Sciences World CongressOctober 4-6, 2020 Virtual Conference
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| POSBAS-001 | A grafted co-polymer based Nanomicelles aided topical ocular delivery for treating posterior uveitis. | Nikita . |  Received |
 |
|||
| POSCAT-001 | Natural products as prospective alternative treatments for neurodegenerative disease | Sunisha Aryal | Received |
|
|||
| PSWCS-001 | Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nan otechnology | Kirill Afonin | Received |
|
|||
| POSDSI-001 | Relationships between serum nivolumab and peripheral blood lymphocyte, serum IgG, or cachexia stage in cancer patients | Kazuki Abe | Received |
|
|||
| POSANC-001 | Blockade of immunosuppression boosts HLA allele-specific idiosyncratic drug toxicity by abacavir in the HLA-transgenic mice | Shigeki Aoki | Received |
|
|||
| POSEMT-002 | Observations of Nursing Practices Related to Drug Preparation and Administration in Care Units: a cross-sectional study | Jean-Franois Bussières | Received |
|
|||
| POSCAT-002 | Evaluation of Doravirine Pharmacokinetics in Pregnant Women using Physiologically-Based Pharmacokinetic Models | Shakir Adeyinka Atoyebi | Received |
|
|||
| POSDSI-002 | Socioeconomic factors influencing antibiotic misuse in patients visiting the general outpatient department, Ahmadu Bello University teaching Hospital, Zaria | Adejoke Adelaja | Received |
|
|||
| POSBAS-002 | Synthesis and characterization of a Metal-Organic Framework (MOF) as a topical delivery system of Sulfadiazine for wound prophylaxis. | Javier Aguila-Rosas | Received |
|
|||
| PSWCS-002 | Evolutionary Therapy for Metastatic Cancer | Alexander Anderson | Received |
|
|||
| POSANC-003 | Dissolving Polymeric Microneedles for the Delivery of Sensors for Real-Time Physiological Monitoring | Samuel Babity | Received |
|
|||
| POSCAT-003 | Dynamical Systems Analysis as an Additional Tool to Improve Immuno-oncology Treatments | Aymen Balti | Received |
|
|||
| POSEMT-003 | Descriptive Pilot Study of Healthcare Workers Exposure to Cyclophosphamide, Ifosfamide, Methotrexate and Fluorouracil by 24-Hour Urine Assay | Jean-Franois Bussières | Received |
|
|||
| POSEMT-004 | Role and impact of pharmacist in Belgium: a scoping review | Jean-Franois Bussières | Received |
|
|||
| PSWCS-004 | Linking otic quinolone and tympanic membrane perforations: Validating pharmacoepidemiologic safety signals with laboratory models | Patrick Antonelli | Received |
|
|||
| POSDSI-004 | Adverse events of SGLT2 inhibitors associated with Health Canada safety warnings: An overview of quantitative systematic reviews. | Wajd Alkabbani | Received |
|
|||
| POSEMT-005 | Design of next-generation peritoneal dialysis fluids for the treatment of Alzheimers Disease | Philippe Delbreil | Received |
|
|||
| POSBAS-005 | DEVELOPMENT AND OPTIMIZATION OF ARTEETHER LOADED NOVEL DRUG DELIVERY SYSTEM USING FORMULATION BY DESIGN CONCEPT FOR INTENSIFIED ORAL BIOAVAILABILITY | Neha Bajwa | Received |
|
|||
| POSCAT-005 | CANDESARTAN CILEXETIL TWO STEP IN VITRO-IN VIVO CORRELATION (IVIVC) | Marival Bermejo Sanz | Received |
|
|||
| POSDSI-005 | Emerging roles for Pharmacists in Mental health care: Assessing mental health literacy among Pharmacists in Nigeria | Deborah Aluh | Received |
|
|||
| POSEMT-006 | Detection of adverse drug reactions from the coding of episodes of care by medical archivists | Amelie Duhamel | Received |
|
|||
| POSCAT-006 | Expansion of a Levonorgestrel Physiologically-Based Pharmacokinetic Model (PBPK) to Evaluate the Pharmacokinetic/Pharmacodynamic (PKPD) Effects of SHBG Protein Binding | Brian Cicali | Received |
|
|||
| POSANC-006 | Identification of a novel inhibitor for hepatitis B virus internalization targeting viral receptor oligomerization | Kento Fukano | Received |
|
|||
| PSWCS-006 | Developing long lasting oral drug delivery systems for infectious disease | Jessica Ballinger | Received |
|
|||
| POSANC-007 | Effect of co-administration of warfarin and prednisolone on anticoagulant therapy and its possible mechanism in relation to the Niemann-Pick C1-like 1-mediated pathway | Sayo M Ito | Received |
|
|||
| POSDSI-007 | Torsades de pointes: Should we really fear psychotropic drugs? | Samuel Cyr | Received |
|
|||
| POSBAS-007 | Administration of ive CD36 (SR-B2) receptor ligands by dissolving microneedle arrays for the treatment of atherosclerosis | Cloe Esposito | Received |
|
|||
| POSCAT-007 | THE EFFECTS OF CITICOLINE IN CHRONIC ISCHEMIA INDUCED BY MOVEMENT RESTRICTION | Tatevik Grigoryan | Received |
|
|||
| POSEMT-007 | Evaluation of the rate of compliance with good pharmacovigilance reporting practices 12 months after their adoption | Amelie Duhamel | Received |
|
|||
| POSDSI-008 | PHARMACEUTICAL ACTIVITIES IN THE NEONATAL INTENSIVE CARE UNIT: AN INTEGRATIVE LITERATURE REVIEW | Marta Maria Fonteles | Received |
|
|||
| POSANC-008 | Flucloxacillin induces liver injury in mice pretreated with a toll-like receptor 9 agonist in mitochondrial permeability transition dependent manner | Yuying Gao | Received |
|
|||
| POSCAT-008 | DYNAMICS OF MATERNAL MORTALITY IN TWO TERTIARY HOSPITALS IN SOUTHEAST NIGERIA: SAVING THE LIVING FROM THE DEAD | Michael Iweh | Received |
|
|||
| POSBAS-008 | Surface properties of PLA-PEG Nanovectors modulates their interactions with brain endothelial cells: inflammatory response versus transcytosis efficiency | Soudeh F.Tehrani | Received |
|
|||
| POSEMT-008 | Insilico Modelling of the thiophene analogues as a PTP1B inhibitors | Sunil Kuamr Dwivedi | Received |
|
|||
| PSWCS-009 | Global omics approach for the development of nanomedicines in cancer; overcoming drug resistance and increasing ivity | Erem Bilensoy | Received |
|
|||
| POSCAT-009 | Plasma concentration changes of endogenous OATP1B1 substrates before and after paclitaxel administration in non-small cell lung cancer | Hiroyuki Kusuhara | Received |
|
|||
| POSEMT-009 | IMPLEMENTATION OF MEDICATION REVIEW TO OUTPATIENTS WITH RHEUMATOID ARTHRITIS IN TEACHING HOSPITAL | Marta Maria Fonteles | Received |
|
|||
| POSDSI-009 | The Future of Pharmacogenomics application in Alberta Community Pharmacies | Dalia Hamdy | Received |
|
|||
| POSANC-009 | Repurposing Angiotensin-Converting Enzyme inhibitors for the treatment of Alzheimers disease: Lessons from a Drosophila model | Patricia Jumbo | Received |
|
|||
| POSCAT-010 | Investigation of intronic polymorphisms and transcription factors responsible for the OCT2 expression | Hiroyuki Kusuhara | Received |
|
|||
| PSWCS-010 | A multi-disciplinary collaboration using pharmacometrics, pharmacoepidemiology, and pharmacoeconomics for efficacy and safety questions related to generic substitution | Joshua Brown | Received |
|
|||
| PSWCS-011 | The Role of microbes in drug responses New models | Filipe Cabreiro | Received |
|
|||
| POSBAS-011 | Specific recognition for target cells using Fab-PLGA/siRNA-PLGA mixed micelles | Mai Hazekawa | Received |
|
|||
| POSDSI-011 | Feasibility study of drug quantification in breast milk by liquid chromatography coupled to mass spectrometry (LC-MS/MS) | Analle Monfort | Received |
|
|||
| POSEMT-011 | Implementation of Pharmacogenomics in Community Pharmacies in Alberta: Perceptions and Challenges | Dalia Hamdy | Received |
|
|||
| POSANC-012 | Pattern of Antibiotics use at the Department of Surgery, Korle-Bu Teaching Hospital | Josephine Mensah | Received |
|
|||
| POSEMT-012 | Analysis of long-term progression of Parkinsons disease by SReFT (Statistical Restoration of Fragmented Time-course) suggested slower progress in patients with LRRK2 G2019S mutation | Akihiro Hisaka | Received |
|
|||
| PSWCS-012 | Targeted Degradation of BTK: a PROTAC case study | Matthew Calabrese | Received |
|
|||
| POSBAS-012 | Polymer-lipid interplay in altering liquid-liquid phase separation and supersaturation evolution of poorly soluble drugs | Jiahao Huang | Received |
|
|||
| POSCAT-012 | First-in-Human Studies of Monoclonal Antibodies in Oncology: An Overview of Study Designs and Stopping Criteria | Man Qing Liang | Received |
|
|||
| POSDSI-012 | Evaluation of intranasal drug delivery devices in its design and usability | Mikio Murata | Received |
|
|||
| POSBAS-013 | L-serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier | Hidemasa Katsumi | Received |
|
|||
| POSEMT-013 | An Assessment of Safety Culture in Saskatchewan Community Pharmacy Practice in Canada | Certina Ho | Received |
|
|||
| PSWCS-013 | Pharmaceutical science degree accreditation - the APS model | William Dawson | Received |
|
|||
| POSDSI-013 | Impact of ISO17025 Laboratory Accreditation in sub-Saharan Africa: A case study | Mercy OKEZUE | Received |
|
|||
| POSCAT-013 | Investigation of fluorescent substrates of a drug transporter organic anion transporting polypeptide 2B1 | Tomohiro NABEKURA | Received |
|
|||
| POSANC-014 | Relationship between genotype and/or phage ORF type of ESBL-producing Escherichia coli and fluoroquinolones resistance | Nobuhiro Nishimura | Received |
|
|||
| POSCAT-014 | Substrate-dependent interactions of organic anion transporting polypeptide 2B1 with natural compounds | Tomohiro NABEKURA | Received |
|
|||
| PSWCS-014 | Training drug hunters - integrating clinical development into a pharmaceutical science degree | Denis deBlois | Received |
|
|||
| POSEMT-014 | Residents Perception of One-Year Industrial Pharmacy Residency Program in Canada | Certina Ho | Received |
|
|||
| POSBAS-014 | Aspartic acid modified dendrimer-based micelle as a highly potent bone resorption surface-targeting nano-carrier for the efficient treatment of bone metastasis | Hidemasa Katsumi | Received |
|
|||
| POSDSI-014 | Validation of an algorithm to predict advanced chronic kidney disease from linked health insurance administrative databases in Quebec | Sylvie Perreault | Received |
|
|||
| POSDSI-015 | Predicting Major Bleeding among Real-World Oral Anticoagulant Users with Atrial Fibrillation | Jakub Qazi | Received |
|
|||
| POSCAT-015 | Mechanistic study of endocrine disruptors induced fetal toxicity: A computational insight | Kalyan Venkata | Received |
|
|||
| POSBAS-015 | TRIPLE COMBINATION OF HERBAL BIOACTIVE MOLECULES LOADED NANOEMULGEL AS A TOPICAL DRUG DELIVERY TO COMBAT ACNE VULGARIS | Karishma khatoon | Received |
|
|||
| POSBAS-016 | Formulation and evaluation of a solid self-emulsifying drug delivery system using an oily liquid model compound | You Zhuan Lee | Received |
|
|||
| POSEMT-016 | Compound Selection assisted by Bayesian Inference of Efficacy Metrics | Caroline Labelle | Received |
|
|||
| PSWCS-016 | Microdialysis as a tool to monitor local exposure of anti-infective agents | Hartmut Derendorf | Received |
|
|||
| POSCAT-016 | Optimizing Cytotoxic Chemotherapy regimens in the Context of Triple Negative Breast Cancer | Rosalba Vivian Paredes Bonilla | Received |
|
|||
| POSCAT-017 | A Bioanalytical Methodology And Pharmacokinetic Evaluation Of Amphotericin B In Healthy And Infected Wistar Rats | Jackeline Marley de Araújo | Received |
|
|||
| POSDSI-017 | Impact of CYP2D6 activity on enantiomeric pharmacokinetics of tramadol and its demethylated metabolites in patients with head and neck cancer | Koji Suzuki | Received |
|
|||
| POSANC-017 | In silico structural analysis of HLA complexes associated with idiosyncratic drug toxicities | Tomohiro SHIRAYANAGI | Received |
|
|||
| PSWCS-017 | How to support healthcare professionals with scientific evaluation of medication errors and, regulatory authorities with medication errors guidance evaluation | Brian Edwards | Received |
|
|||
| POSCAT-018 | The Increasing Challenge of Levodopa Dosing in Parkinson with Disease Progression: Modeling Insights | Florence Véronneau-Veilleux | Received |
|
|||
| POSANC-018 | Pharmacometrics of equivalence for the treatment of ADHD with methylphenidate | Sara Soufsaf | Received |
|
|||
| POSBAS-019 | Transcutol: A promising drug solubilizer suitable for in continuous flow liposome production in a Periodic Disturbance mixer. | Ruben Lopez | Received |
|
|||
| POSANC-019 | Ezetimibe-mediated prevention and recovery of hepatic NPC1L1-dependent dietary steatosis in mice. | Tappei Takada | Received |
|
|||
| POSDSI-019 | Assessment of knowledge, attitude and practice of self- medication among undergraduate medical and paramedical students of Gandaki Medical College, Nepal | Bindu Malla | Received |
|
|||
| PSWCS-019 | Successes and challenges of fecal microbiota transplantation for treating recurrent Clostridioides Difficile | Hala Fadda | Received |
|
|||
| POSEMT-019 | Outcomes from efforts at advancing capacity for manufacturing quality medicines in sub-Saharan Africa - the BIRS program | Mercy OKEZUE | Received |
|
|||
| POSCAT-019 | In Vitro Release Study of Drug-loaded Polymeric Nanoparticles: Using The Appropriate Method | Jingwen Weng | Received |
|
|||
| PSWCS-020 | Toward the efficient discovery of actionable chemical matter from DNA-encoded libraries | Timothy Foley | Received |
|
|||
| POSDSI-020 | Evaluation of Press Through Package(PTP) with the function of Child Resistance and Senior Friendly(CRSF) | Kiyomi Sadamoto | Received |
|
|||
| POSANC-020 | ABCG2 is a physiological exporter of indoxyl sulfate, and its dysfunction accelerates the progression of chronic kidney disease. | Takehito Yamamoto | Received |
|
|||
| POSANC-021 | ATP Metabolism in the Red Blood Cells as Potential Surrogate Biomarker and TherapeuticTarget for Post-Exercise Hypotension and Cardiovascular Protection | Pollen Yeung | Received |
|
|||
| POSEMT-021 | International Standards for Quality Management Systems of Pharmaceutical laboratories; disparities versus similarities | Mercy OKEZUE | Received |
|
|||
| PSWCS-021 | Importance of last-mile delivery of drugs and their rational use by end-users for improved health outcomes | Patrick Gaparayi | Received |
|
|||
| PSWCS-022 | Artificial in vitro biosynthesis for backbone-modified peptides | Yuki Goto | Received |
|
|||
| PSWCS-023 | Overview of 3D printing technologies in pharmaceutical sciences | Alvaro Goyanes | Received |
|
|||
| POSBAS-023 | Investigation of transdermal formulations for improved delivery of phytocannabinoids | Chulhun Park | Received |
|
|||
| POSBAS-024 | Rapid Dissolving Capsules for the Administration of Gastric-resistant Prednisolone Microparticles for Paediatric and Geriatric Patients | Kavil Patel | Received |
|
|||
| PSWCS-024 | HTS in a non-profit environment: The EU perspective | Sheraz Gul | Received |
|
|||
| POSEMT-024 | Deployment of a Web-based Tool Built from Pharmacy Claims Data to Monitor Adherence to Respiratory Medications in Primary Care: A Feasibility Study | Alia Yousif | Received |
|
|||
| POSBAS-025 | Sustained Release Fixed Dose Combination Products in Microparticle-Filled Straw developed using the MicroCoatTM technology | Kavil Patel | Received |
|
|||
| POSEMT-025 | PHARMACEUTICAL INTERVENTIONS AS A TOOL TO REDUCE EMOTIONAL STRESS AND LOW ADHERENCE TO TREATMENT IN PEOPLE WITH DIABETES IN PRIMARY CARE | Reijane Mara Pinheiro Queiroz | Received |
|
|||
| PSWCS-026 | Engineering Delivery Systems for Global Health | Ana Jaklenec | Received |
|
|||
| POSBAS-026 | Instant Jellies as a Potential Delivery Vehicle for the Administration of Sustained Release Microparticles to Improve Palatability of Paediatric and Geriatric Medicines | Kavil Patel | Received |
|
|||
| PSWCS-027 | 3D printing in pharmaceutical sciences - intellectual property aspects | Catherine Jewell | Received |
|
|||
| PSWCS-028 | The use of microdialysis in translational drug development | Francine Johansson Azeredo | Received |
|
|||
| PSWCS-029 | Challenges to Therapeutic Repurposing and Development in a Pandemic. | Steven Kern | Received |
|
|||
| POSBAS-029 | Novel 3D printed capsule with integrated magnetic field triggerable anti-cancer drug delivery system | Kejing Shi | Received |
|
|||
| PSWCS-030 | Ceramide Nanoliposomes: the Road to the Clinic | Mark Kester | Received |
|
|||
| POSBAS-031 | Preparation of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid technology | Madeleine Tan | Received |
|
|||
| POSBAS-032 | Exosomes and Outer membrane Vesicles: In-vivo analysis of Drug Delivery Nanotools | Shindu Thomas | Received |
|
|||
| PSWCS-032 | Microdialysis to monitor target site concentrations of large molecules | Vipada Khaowroongrueng | Received |
|
|||
| PSWCS-033 | Design of oral drugs beyond the rule of 5 Opportunities, some guidelines and challenges | Jan Kihlberg | Received |
|
|||
| POSBAS-033 | BUDESONIDE LOADED COLON TARGETED NANOFIBER DRUG DELIVERY SYSTEM | YAS&304;N TURANLI | Received |
|
|||
| POSBAS-035 | Effects of Labrasol and its related formulations on the intestinal absorption of insulin and elucidation of their absorption enhancing mechanisms | Hiroki Ukai | Received |
|
|||
| POSBAS-036 | Development and Evaluation of Cholecalciferol-loaded PEGylated Nanoparticles for Brain Drug Delivery: Effect of Particle Size | Jingwen Weng | Received |
|
|||
| PSWCS-036 | Translating research into practice: Pharmacists roles to support antimicrobial stewardship -a focus on low-and middle-income countries | Eneyi Kpokiri | Received |
|
|||
| PSWCS-037 | New approaches to tackle antimicrobial resistance : antimicrobials and beyond | Teruo Kuroda | Received |
|
|||
| POSBAS-038 | Evaluating population pharmacokinetic modelling methods to guide individualized dosing when switching to extended half-life products in hemophilia A patients | Jacky Yu | Received |
|
|||
| PSWCS-038 | Pharmacokinetic PET imaging in drug research | Oliver Langer | Received |
|
|||
| PSWCS-039 | Novel Drug Delivery Approaches for Global Health: Challenges & Opportunities | Dennis Lee | Received |
|
|||
| PSWCS-040 | Translating from benchside to bedside | Nathalie Letarte | Received |
|
|||
| POSBAS-040 | Evaluation of the stability, in different relative humidities, of hot melted acetaminophen extrudates for 3D printin | Gabriela Pereira | Received |
|
|||
| POSBAS-041 | Mechanisms of activity loss for a multi-PEGylated protein by experiment and simulation | Ahlem Zaghmi | Received |
|
|||
| PSWCS-041 | Organs-on-Chips: A platform for drug development and disease modeling | Daniel Levner | Received |
|
|||
| PSWCS-042 | Framework to Define Pharmaceutical Supply Chain Vulnerability | Michael Levy | Received |
|
|||
| PSWCS-043 | Implementation of genomics in clinical care | Catalina Lopez-Correa | Received |
|
|||
| PSWCS-044 | UK Cell and Gene Therapy Catapult: A model for the world? | Nuno Madeira do O | Received |
|
|||
| PSWCS-045 | Pharmaceutical science in the development of new medicines - from concept to approval | Takashi Mano | Received |
|
|||
| PSWCS-046 | Tackling antimicrobial resistance through behaviour change approaches | Ayodeji Matuluko | Received |
|
|||
| PSWCS-047 | Modification of the gut microbiota with a prebiotic enhances Immune Checkpoint blockers anti-cancer activity | Meriem Messaoudene | Received |
|
|||
| PSWCS-048 | QSP modeling from population to patient-level predictions in immunotherapy | Oleg Milberg | Received |
|
|||
| PSWCS-049 | How COVID-19 Changedthe Future of Drug R&D? | Bernard Munos | Received |
|
|||
| PSWCS-050 | New insights from uncultivated genomes of the global human gut microbiome | Stephen Nayfach | Received |
|
|||
| PSWCS-051 | Towards stratified medicine approaches using nano-technology-based drug delivery systems: A focus on infectious diseases | Andrew Owen | Received |
|
|||
| PSWCS-052 | Targeting Intracellular Protein-Protein Interactions with Macrocyclic Peptides | Dehua Pei | Received |
|
|||
| PSWCS-053 | Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate | James Polli | Received |
|
|||
| PSWCS-054 | 3D printing in oral dosage | Julian Quodbach | Received |
|
|||
| PSWCS-055 | Towards digital pharmaceutical care | Claudia Rijcken | Received |
|
|||
| PSWCS-056 | How translational sciences are harnessed to face COVID-19 | Joni Rutter | Received |
|
|||
| PSWCS-057 | 3D Printing of Gene Activated Matrices for Bone Tissue Engineering | Aliasger Salem | Received |
|
|||
| PSWCS-059 | Significance - developed large scale docking en route towards the first billion-compound virtual library | Brian Shoichet | Received |
|
|||
| PSWCS-061 | Delivering nanomedicines to the upper and lower airways | Fabio Sonvico | Received |
|
|||
| PSWCS-062 | Dicloxacillin in drug-drug interactions a translational tale from registries to the bench and back again | Tore B. Stage | Received |
|
|||
| PSWCS-065 | Balancing basic and clinical pharmaceutical science in a pharmacy degree | Craig Svensson | Received |
|
|||
| PSWCS-066 | Pharmacogenomics and pharmacotherapy of common diseases: prescribing the right drug at the right dosage for the right person | Jean-Claude Tardif | Received |
|
|||
| PSWCS-068 | Impacts of large scale adoption of genomics in a health-care system | Jacques Turgeon | Received |
|
|||
| PSWCS-071 | Roles of Systems Pharmacology in Developing Personalized Cancer Treatment Regimens | Paolo Vicini | Received |
|
|||
| PSWCS-073 | Opportunities and barriers of joint approaches to enhance causal inference on drug effects | Almut Winterstein | Received |
|
|||
| PSWCS-075 | Privacy Preserving Artificial Intelligence for Tx Selection | Alexandre LeBouthillier | Received |
|
|||
| PSWCS-077 | Potential of AI in predicting translational success of drug candidates through clinical research | Massimo Riccaboni | Received |
|
|||
| PSWCS-078 | Oral Presentation | Elias Gedamu | Received |
|
|||
| PSWCS-079 | Oral Presentation | Rodi Abdalkader | Received |
|
|||
| PSWCS-083 | Oral Presentation | Sven Ansorge | Received |
|
|||
| PSWCS-085 | Oral Presentation | Man Zawati | Received |
|
|||
| PSWCS-088 | Oral Presentation | Fouad Atouf | Received |
|
|||
| PSWCS-089 | Oral Presentation | Steven Keizer | Received |
|
|||
| PSWCS-090 | Tacking medication price hike: A case for patent-free drugs | Serge Afeli | Received |
|
|||
| PSWCS-091 | Oral Presentation | Frank Gupton | Received |
|
|||
| PSWCSUB-922 | Paper-Based Diagnostic Devices for Monitoring Drug Therapy: Focus on Anticoagulation | Daniel Zaldumbide | Received |
|
|||
INTERNATIONAL PHARMACEUTICAL FEDERATION
7th FIP Pharmaceutical Sciences World Congress
October 4-6, 2020 Virtual Conference
HELP LINE
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 29/09/2020 TO 04/10/2021
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 05/10/2020
|
|
